Literature DB >> 6890386

[Density distribution of human lymphocytes. II. Distribution patterns of malignant lymphocytes and their prognostic significance in patients with non-Hodgkin's lymphoma].

D Niederwieser, C Huber, D Lutz, G Weiser, H Theml, H Braunsteiner.   

Abstract

The aim of this study was to investigate the prognostic significance of density distribution profiles in non-Hodgkin lymphomas. Density profiles were evaluated by equilibrium centrifugation on linear polysucrose-metrizoat gradients. Biopsy cells from 44 untreated non-Hodgkin lymphomas in advanced stages according to their density patterns could be classified into one of two distinct groups: Group A lymphomas exhibited high to intermediate densities and resembled normal resting B or T lymphocytes; they showed low spontaneous proliferation and favourable histologies. Group B lymphomas exhibited light densities, resembling activated lymphocytes and frequently revealed high spontaneous proliferation and unfavourable histology. Within a minimal time of observation of 40 months only 28% of the group A but 75% of the Group B lymphomas died. Simultaneously performed surface marker studies excluded the possibility that variable proportions of normal lymphocytes contaminating the lymphoma suspensions are responsible for the two density groups. They rather suggested that these patterns reflect the individual capacity of a lymphoma to differentiate into denser tumour clones with low spontaneous proliferation. We therefore conclude that analyses of density profiles from non-Hodgkin lymphomas represenmts a promising method for the prognostic classification of this disease.

Entities:  

Mesh:

Year:  1982        PMID: 6890386     DOI: 10.1007/bf00320549

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  10 in total

1.  Linear density gradient separation of human lymphocyte subsets. I. Analysis by mixed leukocyte culture and cell-mediated lympholysis responses.

Authors:  K S Zier; C Huber; H Braunsteiner
Journal:  Eur J Immunol       Date:  1977-06       Impact factor: 5.532

2.  Decreased proliferative activity of erythroblasts in granulocytic stem cell leukaemia.

Authors:  C Huber; H Huber; F Schmalzl; H Braunsteiner
Journal:  Nature       Date:  1971-01-08       Impact factor: 49.962

3.  A comparative study of the buoyant density distribution of normal and malignant lymphocytes.

Authors:  C Huber; K Zier; G Michlmayr; H Rodt; K Nilsson; H Theml; D Lutz; H Braunsteiner
Journal:  Br J Haematol       Date:  1978-09       Impact factor: 6.998

4.  Receptor sites for aggregated gammaglobulin (AGG) on lymphocytes in lymphoproliferative diseases.

Authors:  C Huber; E Dworzak; U Fink; G Michlmayr; H Brunsteiner; H Huber
Journal:  Br J Haematol       Date:  1974-08       Impact factor: 6.998

5.  Expression and specificity of FcIgG receptor sites on neoplastic lymphocytes.

Authors:  C Huber; H D Flad; K Nilsson; H Wigzell; G Michlmayr; H Frischauf; H Braunsteiner
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

6.  [Radiotherapy in non-Hodgkin lymphoma].

Authors:  K Musshoff
Journal:  Internist (Berl)       Date:  1980-09       Impact factor: 0.743

7.  [Chemotherapy in non-Hodgkin lymphoma].

Authors:  K Bremer; P Meusers; G Brittinger
Journal:  Internist (Berl)       Date:  1980-09       Impact factor: 0.743

8.  Prognostic significance of lymphocyte density distribution profiles in adult non-Hodgkin lymphomas.

Authors:  C Huber; D Lutz; D Niederwieser; G Weiser; O Dietze; H Theml; H Braunsteiner
Journal:  Blood       Date:  1982-12       Impact factor: 22.113

9.  [Density distribution of human lymphocytes. I. Results of research on normal lymphoid tissue].

Authors:  C Huber; D Niederwieser; G Gastl; K Zier; H Braunsteiner
Journal:  Blut       Date:  1982-12

10.  Correlation of cell kinetic findings with morphology of non-Hodgkin's malignant lymphomas.

Authors:  R Silvestrini; R Piazza; A Riccardi; F Rilke
Journal:  J Natl Cancer Inst       Date:  1977-03       Impact factor: 13.506

  10 in total
  1 in total

1.  [Neopterin, a new biochemical marker for clinical assessment of cell-mediated immune response].

Authors:  C Huber; D Fuchs; D Niederwieser; A Hausen; G Reibnegger; K Nilsson; H Wachter
Journal:  Klin Wochenschr       Date:  1984-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.